Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 120.20 Delayed Data As of 3:59pm ET |  -2.81 / -2.28%Today’s Change | 72.14 Today|||52-Week Range 136.26 | +11.82% Year-to-Date |
Latest NBIX News | Press Releases
No recent news for Neurocrine Biosciences Inc.
Today’s Trading
| Previous close | 123.01 |
| Today’s open | 126.70 |
| Day’s range | 119.20 - 126.70 |
| Volume | 53,771 |
| Average volume (3 months) | 835,358 |
| Market cap | $11.4B |
Data as of 3:59pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +72.61% |
| Earnings growth (this year) | +643.45% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +74.65% |
| P/E ratio | 63.3 |
| Price/Sales | 13.06 |
| Price/Book | 17.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TECHBio-Techne Corp | -2.54 | -0.91% |
| IMMUImmunomedics Inc | -0.31 | -0.70% |
| NVAXNovavax Inc | +1.22 | +0.78% |
| EXASExact Sciences Corp | -2.14 | -2.25% |
Data as of 7:57pm ET, 08/04/2020
Financials
| Next reporting date | October 28, 2020 |
| EPS forecast (this quarter) | $0.27 |
| Annual revenue (last year) | $788.1M |
| Annual profit (last year) | $37.0M |
| Net profit margin | 4.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
